跳至主要内容
临床试验/ISRCTN26340837
ISRCTN26340837已完成不适用

Effect of recombinant Granulocyte Colony-Stimulating Factor (G-CSF) on the results of chemotherapy (CHOP) in elderly patients with intermediate-/high-grade Non-Hodgkin's Lymphoma: a prospective phase III study

Dutch Haemato-Oncology Association (Stichting Hemato-Oncologie Volwassenen Nederland) (HOVON) (Netherlands)0 个研究点目标入组 410 人开始时间: 2005年12月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
410

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Previously untreated Non-Hodgkin?s Lymphoma
  • 2. Ann Arbor stage II, III or IV
  • 3. Intermediate- or high grade malignancy (Working Formulation), confirmed by histology
  • 4. Aged greater than or equal to 65 years
  • 5. Informed consent

排除标准

  • 1. Treatment for NHL with chemotherapy or radiotherapy (local irradiation to life-threatening tumor infiltration is allowed)
  • 2. Lymphoblastic lymphoma
  • 3. Other malignant diseases, except localized squamous skin carcinoma
  • 4. Severe heart failure requiring symptomatic treatment or a cardiac ejection fraction of less than 45%
  • 5. Inadequate liver or renal function, ie serum creatinine or serum bilirubin > 15x the upper normal value, except when related to lymphoma organ infiltration
  • 6. HIV positivity

研究者

发起方
Dutch Haemato-Oncology Association (Stichting Hemato-Oncologie Volwassenen Nederland) (HOVON) (Netherlands)

相似试验